German measles vaccine

German measles vaccine is a vaccine used to prevent German measles, also known as Rubella. The vaccine is typically administered in combination with the measles vaccine and mumps vaccine, a combination referred to as the MMR vaccine.

History

The German measles vaccine was first developed in the 1960s. Prior to the development of the vaccine, German measles was a common childhood illness. However, the disease can have serious complications, particularly in pregnant women, leading to the development of the vaccine.

Effectiveness

The German measles vaccine is highly effective at preventing the disease. According to the World Health Organization, more than 95% of people who receive the vaccine develop immunity to German measles.

Administration

The German measles vaccine is typically administered in two doses. The first dose is usually given at 12 to 15 months of age, and the second dose is given at 4 to 6 years of age. However, the timing of the doses can vary depending on the country's vaccination schedule.

Side effects

Like all vaccines, the German measles vaccine can have side effects. However, these are usually mild and temporary. Common side effects include fever, rash, and swelling of the glands in the neck or cheeks.

Global impact

The German measles vaccine has had a significant impact on global health. Since the introduction of the vaccine, the number of cases of German measles has decreased dramatically. In 2015, the World Health Organization declared the Americas to be free of German measles, thanks to widespread vaccination.

See also

• Vaccination
• MMR vaccine
• Rubella
• Measles vaccine
• Mumps vaccine